It would take us into an area where we have not been before. That's going to be a completely different area. We do have expertise in terms of the data on pharmacare. Carleigh is obviously an expert in our office now, but in terms of getting the health benefits of this, it is moving a couple of steps beyond what we normally do.
On October 17th, 2017. See this statement in context.